home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 15, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 549 active entries

Seco-Steroidal Drug Discovery

P. O. B. 1, UNSW (Syd) Kensington NSW 2033
Canada
Canada
Toll free: +011-604-941-9022

Phone: +011-604-945-8408
Fax: +011-604-941-9022

Description:

Our Seco-Steroidal Chemistry:

Our projects are exclusively our own proprietary property and meant for information purposes only. We began with our Principal Investigators work earlier in the 1980 with plant product Lanosterol at Simon Fraser University BC CANADA which led later to our work on drug therapy with VitD metabolism as it applies to chronic or acute inflammation and related occupational-related or life-style diseases such as diabetes type2, atherosclerosis or heart disease and certainly some if most cancers (e. g. breast and colon). 

[1] Seco-steroidal drugs to effect receptors on the cell membrane involved to therapeutically address cholesterol uptake at the gut level and metabolically, post-absorptively (readily on the market).

[2] Seco-steroidal drugs to effect antagonism of feed-back inhibition (FBI) VitD effector functions and prolong their active state as with our Retonobionols (R) to help control of prevent the prevalence of cancers and other chronic inflammatory disease conditions of the body.

[3] Steroidal analogues to compete with and control, via this pharma, the esterifications and storage of cholesterol in shell eggs with poultry. This proposal further expands on (see: [2] above) the theme of cholesterol whole-body metabolism and its emptying into the digestive tract through bile juice from the duct.

[4] Steroidal analogues in plant secoundary alkaloid derivatives that bind to mother cell mitotic spindle fibres and prevent pollination in genetically manipulated biosafe plant life.

Since 1992 until it closing in 1995 after achieving honours standing in lab bench research performance with his work from an NSERC/MRC Canadian grant and then an OPRS award from Australia, our Principal Investigator plans to continue publishing his own research results on seco-steroidal drug discovery. He currently is on partial foundational granting from the Canadian Academy of Independent Scholars, SFU.ca, Adult Continuing Education, downtown Vancouver, BC. 

SKYE BLUE INTERNET ® 

All copyright held by D. A. Flores. 2003-2016. All rights reserved. Disclaimer.  

Information in Companies. Working for Information.

Made for Information. ® 

 



Selected Categories:
Product Company   Service Company
Consulting
- General
Contract
- Research
Professional
- Communications

Last update of this entry: September 03, 2018

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.